See also this year's filing and all EDGAR filings for this company.
PDF Report 0001087294_2016_Cumberland_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001087294, Cumberland Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 67,112,074 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 21,168,596 |
| 2 | PropertyPlantAndEquipmentNet | 536,450 |
| 3 | remainder_Assets | 3,101,839 |
| 4 | LiabilitiesCurrent | 12,411,747 |
| 5 | LiabilitiesNoncurrent | 987,429 |
| 6 | remainder_Liabilities | 1,700,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,612,548 |
| 9 | ResearchAndDevelopmentExpense | 3,822,044 |
| 10 | remainder_Expenses | 21,709,331 |
| 11 | remainder_Revenues | 33,712,038 |
| 12 | remainder_NetIncome | 200,254 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 91,918,959 |
| 1 | Liabilities | 15,099,176 |
| 2 | Expenses | 33,143,923 |
| 3 | Revenues | 33,712,038 |
| 4 | StockholdersEquity | 76,819,783 |
| 5 | NetIncome | 768,369 |
| 6 | ComprehensiveNetIncome | 768,369 |
| 7 | BaseVar | 87,037,175 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.14 |
| 9 | EconomicCapitalRatio | 3.78 |